145 related articles for article (PubMed ID: 30140631)
1. Long-term effect of triamcinolone acetonide in the treatment of upper lid retraction with thyroid associated ophthalmopathy.
Xu DD; Chen Y; Xu HY; Li H; Zhang ZH; Liu YH
Int J Ophthalmol; 2018; 11(8):1290-1295. PubMed ID: 30140631
[TBL] [Abstract][Full Text] [Related]
2. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy.
Xu D; Liu Y; Xu H; Li H
Can J Ophthalmol; 2012 Feb; 47(1):34-41. PubMed ID: 22333849
[TBL] [Abstract][Full Text] [Related]
3. [Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy].
Luo LH; Gao LX; Wang W; Miao H; Ma XM; Li DM
Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):524-529. PubMed ID: 32842335
[No Abstract] [Full Text] [Related]
4. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease.
Lee JM; Lee H; Park M; Baek S
J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303
[TBL] [Abstract][Full Text] [Related]
5. Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series.
Chee E; Chee SP
Eye (Lond); 2008 Feb; 22(2):311-5. PubMed ID: 17917686
[TBL] [Abstract][Full Text] [Related]
6. Triamcinolone acetonide injection in the treatment of upper eyelid retraction in Graves' ophthalmopathy evaluated by 3.0 Tesla magnetic resonance imaging.
Duan M; Xu DD; Zhou HL; Fang HY; Meng W; Wang YN; Jin ZY; Chen Y; Zhang ZH
Indian J Ophthalmol; 2022 May; 70(5):1736-1741. PubMed ID: 35502063
[TBL] [Abstract][Full Text] [Related]
7. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.
Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823
[TBL] [Abstract][Full Text] [Related]
8. The functional and histopathologic change in the levator palpebrae superioris and Müller muscle after subconjunctival injection of triamcinolone acetonide.
Chang M; Lee Y; Baek S
J Craniofac Surg; 2015 Jan; 26(1):285-9. PubMed ID: 25569401
[TBL] [Abstract][Full Text] [Related]
9. Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves' orbitopathy with unilateral upper eyelid retraction.
Byun JS; Lee JK
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):2001-2008. PubMed ID: 29959506
[TBL] [Abstract][Full Text] [Related]
10. Triamcinolone injection in the treatment of lid retraction for thyroid-associated ophthalmopathy: A systematic review.
Badjrai RA; Eldinia LR; Anandi L; Azhari FO; Anggraini E; Budihardja BM; Nusanti S
Eur J Ophthalmol; 2024 May; ():11206721241254405. PubMed ID: 38751133
[TBL] [Abstract][Full Text] [Related]
11. Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection Method.
Young SM; Kim YD; Lang SS; Woo KI
Ophthalmic Plast Reconstr Surg; 2018; 34(6):587-593. PubMed ID: 29672347
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease.
Kozaki A; Nakamura H; Inoue T
Int Med Case Rep J; 2018; 11():325-331. PubMed ID: 30519121
[TBL] [Abstract][Full Text] [Related]
13. Intraorbital Steroid Injection for Active Thyroid Ophthalmopathy.
Bagheri A; Abbaszadeh M; Yazdani S
J Ophthalmic Vis Res; 2020; 15(1):69-77. PubMed ID: 32095211
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Therapy for Graves' Ophthalmopathy-Associated Eyelid Retraction: Steroid, 5-FU, and Botulinum Neurotoxin a Combination.
Kim Y; Lew H
J Clin Med; 2024 May; 13(10):. PubMed ID: 38792551
[No Abstract] [Full Text] [Related]
15. Change in upper eyelid position after teprotumumab treatment for thyroid eye disease.
Rosenblatt TR; Chiou CA; Yoon MK; Lee NG; Wolkow N; Freitag SK
Orbit; 2024 Jun; 43(3):337-343. PubMed ID: 38466206
[TBL] [Abstract][Full Text] [Related]
16. A Promising Modified Procedure for Upper Eyelid Retraction-Associated Graves' Ophthalmopathy: Transconjunctival Lateral Levator Aponeurectomy.
Khatavi F; Nasrollahi K; Zandi A; Panahi M; Mortazavi M; Pourazizi M; Ranjbar-Omidi B
Med Hypothesis Discov Innov Ophthalmol; 2017; 6(2):44-48. PubMed ID: 29367934
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid gel injection for dysthyroid upper eyelid retraction in Asian patients.
Young SM; Kim JH; Kim YD; Karnsiritanont V; Lang SS; Woo KI
Orbit; 2023 Aug; 42(4):389-396. PubMed ID: 36082627
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Levator-Muller's Complex Thickness on Ultrasound Biomicroscopy to Botulinum Toxin A Injection in Thyroid-Related Upper Eyelid Retraction.
Kandasamy S; Agrawal S; Pushker N; Meel R; Bajaj MS; Thirumurthy V; Jyotsna VP
J Ultrasound Med; 2023 Feb; 42(2):399-408. PubMed ID: 35546328
[TBL] [Abstract][Full Text] [Related]
19. Peri-levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease-associated upper eyelid retraction.
Joos ZP; Sullivan TJ
Clin Exp Ophthalmol; 2017 Aug; 45(6):651-652. PubMed ID: 28248444
[No Abstract] [Full Text] [Related]
20. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
